Zhu Jingyi | Cataract | Excellence in Research Award

Published on by Book of Award

Dr. Zhu Jingyi | Cataract | Excellence in Research Award

The General Hospital of Central Theater Command | China

Dr. Zhu Jingyi is an emerging researcher in vision science and ophthalmic biology, with a focused research profile encompassing retinal pathophysiology, neuroprotection, and molecular mechanisms of ocular diseases. The scholarly output comprises 8 research documents, which have received 89 citations from 87 citing publications, yielding an h-index of 6, reflecting growing academic impact. The research explores cellular and metabolic responses in glaucoma, retinal ischemia–reperfusion injury, and optic nerve damage, with particular emphasis on water transport regulation, ferroptosis, oxidative stress, and energy metabolism in retinal cells. Significant contributions include studies on AQP1-mediated lens physiology, DJ-1–saRNA–based nucleic acid delivery systems for retinal protection, and signaling pathways such as Rap1, YAP/TAZ, and Warburg-like glycolysis in retinal ganglion cell survival. This body of work advances mechanistic understanding and therapeutic strategies for degenerative and ischemic eye diseases.

Citation Metrics (Scopus)

100
80
60
40
0

Citations
89

Documents
8

h-index
6

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Elena Cantone | Medicine and Dentistry | Research Excellence Award

Published on by Book of Award

Prof. Dr. Elena Cantone | Medicine and Dentistry | Research Excellence Award

University of Calabria | Italy

Prof. Dr. Elena Cantone is a highly accomplished researcher in the field of otorhinolaryngology, with a strong and sustained impact on clinical and translational research. Her scholarly output comprises 126 peer-reviewed documents, which together have received 1,953 citations from 1,649 citing documents, reflecting wide international recognition of her work. She maintains an h-index of 25, underscoring both the productivity and consistent influence of her research contributions. Her publications address key topics in chronic rhinosinusitis with nasal polyps (CRSwNP), severe asthma comorbidities, cystic fibrosis–related ENT manifestations, nasal cytology, biologic therapies, and multidisciplinary management strategies. She has played a significant role in advancing real-world evidence on biologic treatments such as dupilumab and mepolizumab, contributing to clinical guidelines, composite severity scoring systems, and long-term outcome assessments. Her research is frequently published in high-impact international journals including Allergy, Clinical Otolaryngology, Journal of Clinical Medicine, Journal of Cystic Fibrosis, The Laryngoscope, and Current Allergy and Asthma Reports. Through collaborative, multicenter studies and clinically driven investigations, her work continues to shape evidence-based practice and improve understanding of inflammatory and airway diseases at both national and international levels.

 

Citation Metrics (Scopus)

2000
1500
1000
500
0

Citations
1,953

h-index
25

Documents
126

Citations

h-index

Documents


View Scopus Profile

Featured Publications

Anna Schiefer | Medicine and Dentistry | Research Excellence Award

Published on by Book of Award

Ms. Anna Schiefer | Medicine and Dentistry | Research Excellence Award

Charité – Universitätsmedizin Berlin | Germany

Ms. Anna Schiefer is an emerging researcher whose work focuses on fracture-related infections, prosthetic joint infections, and regenerative approaches in orthopaedics and traumatology. Her research has been presented at several major international conferences, including the Fracture-Related Infections Workshop and Prosthetic Joint Infections Workshop hosted by the PRO-IMPLANT Foundation, as well as the 6th Congress of the European Society of Tissue Regeneration in Orthopaedics and Traumatology and multiple annual meetings of the European Bone and Joint Infection Society. She has contributed posters and oral presentations highlighting key findings from her doctoral research on infection characteristics and outcomes following intramedullary nailing in femur and tibia fractures. Her scholarly engagement began early, with participation in academic meetings such as the Material Driven Regeneration Annual Meeting, Orthopedic Science Day at Maastricht University, the Omkadering van Jonge Onderzoekers Initiative at KU Leuven, and the MOSA biomedical research conference. She has received competitive scholarships from the PRO-IMPLANT Foundation to support cohort studies on fracture-related and prosthetic joint infections, reflecting the clinical relevance of her work. Her contributions have earned notable recognition, including the Silver Prize for Free Papers at the 6th ESTROT Congress. Her 2026 journal article in Injury further underscores her contributions to infection research within trauma surgery.

Profile : Orcid

Featured Publication

**Schiefer, A., Renz, N., Steiner, G., Märdian, S., Stöckle, U., Trampuz, A., & Meller, S. (2026). Infection after intramedullary nailing for femur and tibia fractures: Characteristics and outcome analysis. Injury.

Yucheng Lu | Neuroscience | Research Excellence Award

Published on by Book of Award

Prof. Yucheng Lu | Neuroscience | Research Excellence Award

Linyi People's Hospital | China

Prof. Yucheng Lu is a distinguished researcher whose scholarly contributions span cancer biology, immunology, and translational biomedical sciences. With 352 citations, 26 indexed publications, and an h-index of 13, he has established a strong research footprint in molecular oncology and disease pathology. Over his academic career, he has published 40 peer-reviewed papers, including 25 as first or corresponding author, reflecting consistent leadership in scientific inquiry. His work encompasses cutting-edge topics such as tumor-associated macrophage regulation in glioma, prognostic biomarkers in low-grade glioma, colorectal cancer therapeutics, and single-cell transcriptomics in esophageal cancer. In addition, he has explored metabolic and immunological disease interactions, cancer proliferation mechanisms, and neural electrophysiological responses. As a principal investigator, he has led 7 provincial and municipal research projects and contributed to 8 national and ministerial-level initiatives, demonstrating strong project management and interdisciplinary collaboration. His research excellence has earned 3 Science and Technology Achievement Awards, alongside innovations represented by 1 invention patent and 6 software copyrights. Through these achievements, Prof. Lu continues to advance biomedical research with significant scientific, clinical, and technological impact.

Profile : Scopus | Orcid

Featured Publications

Shi, H., Cheng, Y., Chao, D., Song, Q., Han, L., Li, H., Lu, Y., & Wang, M. (2025). Spatiotemporal profiling of endocytic regulators in the immunosuppressive TAM microenvironment of glioma. Brain Research, 150086. (In press)

Author names not provided. (2025). Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma. Scientific Reports.

Author names not provided. (2025). Okanin suppresses the growth of colorectal cancer cells by targeting Peroxiredoxin 5. Advanced Science.

Shi, K., Li, Y., Yang, L., Zhang, Z., Guo, D., Zhang, J., & Lu, Y. (2022). Profiling transcriptional heterogeneity of epithelium, fibroblasts, and immune cells in esophageal squamous cell carcinoma by single-cell RNA sequencing. The FASEB Journal, 0892-6638.

Zhao, J. Z., Lu, Y. C., Wang, Y. M., Xiao, B. L., Li, H. Y., Lee, S. C., & Wang, L. J. (2022). Association between diabetes and acute lymphocytic leukemia, acute myeloid leukemia, non-Hodgkin lymphoma, and multiple myeloma. International Journal of Diabetes in Developing Countries, 0973-3930.

Shi, K., Zhang, J. Z., Yang, L., Li, N. N., Yue, Y., Du, X. H., Zhang, X. Z., Lu, Y. C., & Guo, D. (2021). Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma. BMC Cancer, 1471-2407.

Lu, Y., Lv, B., & Song, Q. (2019). Transcranial electrical stimulation motor-evoked potentials in a spinal cord ischaemia rabbit model. Chinese Neurosurgical Journal, 2057-4967.

Lu, Y. C., Wang, P., Wang, J., Ma, R., & Lee, S. C. (2019). PCNA and JNK1-Stat3 pathways respectively promote and inhibit diabetes-associated centrosome amplification by targeting the ROCK1/14-3-3σ complex in human colon cancer HCT116 cells. Journal of Cellular Physiology.

Lingmin Zhang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Book of Award

Prof. Lingmin Zhang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Guangzhou Medical University | China

Prof. Lingmin Zhang is a leading researcher whose work integrates pharmaceutics, biomedical materials, and gene delivery, contributing significantly to advanced therapeutic strategies, particularly in lung cancer and inflammatory diseases. With 3,077 citations , 79 publications, and an h-index of 27, the researcher's scholarly impact is widely recognized. The work focuses on innovative nano-based and biomimetic delivery platforms, including nano-PROTACs, exosomes, microfluidic nanovesicles, and CRISPR/Cas9 carriers, offering transformative possibilities for targeted and precision medicine. Supported by major grants from the National Natural Science Foundation of China (projects 82572415, 82072047, 81700382), the researcher has developed cutting-edge strategies such as reprogramming tumor-associated macrophages, overcoming drug resistance in lung cancer, and reversing epigenetic silencing through nanoparticle-mediated gene delivery. Influential publications in high-impact journals—including Journal of Controlled Release, Drug Resistance Updates, ACS Nano, Angewandte Chemie, Advanced Science, and Molecular Cancer—highlight breakthroughs in nano-therapeutics, PROTAC technologies, artificial exosomes, and nucleic-acid delivery systems. Collectively, these contributions position the researcher at the forefront of translational nanomedicine, with ongoing work offering new directions for precision oncology, regenerative strategies, and next-generation drug delivery platforms.

Profile : Scopus | Orcid

Featured Publication

He, M., Peng, Q., Yang, Q., Guan, X., Liu, Q., Chen, R., Zhou, D., Wang, L., Zhang, Y., Li, S., Su, J., & Zhang, L. (2026). In situ reprogramming of tumor associated macrophages with versatile nano-epigenetic inhibitor for lung cancer therapy. Journal of Controlled Release, 2026, 114497.

Zhang, L., He, L., Lin, Y., Wei, J., Tang, S., Lei, X., Lin, X., Zhou, D., Fu, L., Li, Y., He, J., Liang, L., & Yu, X. (2026). The novel strategy to overcome drug-resistant lung cancer: Dual targeting delivery of PROTAC to inhibit cancer-associated fibroblasts and lung cancer cells. Drug Resistance Updates, 84, 101316.

Chen, S., Chen, E., Su, J., Gong, Y., Tang, S., Qin, A., Shen, A., Tang, S., & Zhang, L. (2025). Magnetically navigated nano-PROTAC ameliorates acute lung injury. Journal of Nanobiotechnology, 23, 622.

Li, X., Qin, Z., Wang, S., Zhang, L., & Jiang, X. (2025). Microfluidics-assembled nanovesicles for nucleic acid delivery. Accounts of Chemical Research, 58, 570–582.

Liang, L., Peng, W., Qin, A., Zhang, J., Chen, R., Zhou, D., Zhang, X., Zhou, N., Yu, X., & Zhang, L. (2024). Intracellularly synthesized artificial exosome treats acute lung injury. ACS Nano, 18(32), 21009–21023.

Guan, X., Xu, X., Tao, Y., Deng, X., He, L., Lin, Z., Chang, J., Huang, J., Zhou, D., Yu, X., Wei, M., & Zhang, L. (2024). Dual targeting and bioresponsive nano-PROTAC induced precise and effective lung cancer therapy. Journal of Nanobiotechnology, 22, 692.

Zhang, L., Lin, Y., Li, S., Guan, X., & Jiang, X. (2023). In situ reprogramming of tumor-associated macrophages with internally and externally engineered exosomes. Angewandte Chemie International Edition, 62(11), e202217089.

Liang, L., Cen, H., Huang, J., Qin, A., Xu, W., Wang, S., Chen, Z., Tan, L., Zhang, Q., Yu, X., Yang, X., & Zhang, L. (2022). The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy. Molecular Cancer, 21(1), 186.

Zhang, H., Peng, R., Chen, S., Shen, A., Zhao, L., Tang, W., Wang, X., Li, Z., Zha, Z., Yi, M., & Zhang, L. (2022). Versatile nano-PROTAC-induced epigenetic reader degradation for efficient lung cancer therapy. Advanced Science, 9(29), 2202039.

Zhang, L., Wang, L., Xie, Y., Wang, P., Deng, S., Qin, A., Zhang, J., Yu, X., Zheng, W., & Jiang, X. (2019). Triple-targeting delivery of CRISPR/Cas9 to reduce the risk of cardiovascular diseases. Angewandte Chemie International Edition, 58(36), 12404–12408.

Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Dr. Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Humanitas Consortium University - ARTOI Foundation | Italy

Prof. Dr. Massimo Bonucci is a distinguished researcher whose scholarly contributions span integrative oncology, cancer therapeutics, and complementary medical approaches. With 153 citations from 153 documents, 20 published documents, and an h-index of 8, his scientific work reflects a growing influence in evidence-based integrative cancer research. His publications demonstrate a strong focus on combining conventional oncology with complementary modalities to enhance patient outcomes, as seen in studies addressing glioblastoma survival, integrative management of myeloproliferative neoplasms, and the synergistic effects of natural compounds such as curcumin, polydatin, and epigallocatechin gallate. His research portfolio includes influential articles in journals such as Journal of Clinical Medicine, Cancers, Onco, Journal of Integrative and Complementary Medicine, and the International Journal of Integrative Oncology, covering topics from locoregional hyperthermia to hematologic diseases, qualitative patient-care insights, and global initiatives in integrative oncology. Recent works explore advancements in dietary supplements, hyperthermia applications, patient-centered care strategies, and international collaborations within the integrative oncology community. Through his continuous contributions and multidisciplinary perspective, Prof. Dr. Bonucci has helped expand the scientific foundation of integrative oncology, supporting its development as a complementary framework within modern cancer research.

Profiles : Scopus | Orcid

Featured Publications

Andreazzoli, F., Yurkovski, I. L., Gowin, K., & Bonucci, M. (2025). Management of myeloproliferative neoplasms: An integrative approach. Journal of Clinical Medicine.

Bonucci, M., Fuggetta, M. P., Anelli, L., Giannarelli, D., Fiorentini, C., & Ravagnan, G. (2025). New approach for enhancing survival in glioblastoma patients: A longitudinal pilot study on integrative oncology. Cancers.

Fiorentini, G., Sarti, D., Mambrini, A., Mattioli, G., Bonucci, M., Ginocchi, L., Cristina, G., Ranieri, G., Bonanno, S., Milandri, C., et al. (2025). Locoregional hyperthermia in cancer treatment: A narrative review with updates and perspectives. Onco.

Bonucci, M. (2025). Superior oral bioavailability of epigallocatechin gallate from TèPigal 300®, a dietary supplement versus a cup of green tea. Journal of Clinical Medical Research.

Stylianou, K., Fuller-Shavel, N., Ghelman, R., Ben-Arye, E., Bonucci, M., Jia, L., Narayanan, S., & Rao, S. (2025). Bridging borders in integrative oncology: A global initiative by the Society for Integrative Oncology. Journal of Integrative and Complementary Medicine.

Bonucci, M. (2025). Introduction to hematologic diseases and integrative therapies: The use of natural supplements and complementary therapies with clinical and preclinical evidence. Figshare.

Chiarlone, P. (2024). Words are life: Written memories in the hospice experience—A qualitative study. International Journal of Integrative Oncology.

Serafino, A., Krasnowska, E. K., Romanò, S., De Gregorio, A., Colone, M., Dupuis, M. L., Bonucci, M., Ravagnan, G., Stringaro, A., & Fuggetta, M. P. (2024). The synergistic combination of curcumin and polydatin improves temozolomide efficacy on glioblastoma cells. International Journal of Molecular Sciences.

Mazzotti, E. (2024). Physical activity in the treatment of cancer patients: An online survey for Italian oncologists and radiotherapists. International Journal of Integrative Oncology.

Mazzotti, E. (2024). Letter to editor on: A feasibility study for the acceptability of virtual reality for patients with cancer undergoing treatment. International Journal of Integrative Oncology.

Cracolici, F. (2024). Improving the quality of life of breast cancer patients with integrated medicine techniques. International Journal of Integrative Oncology.

Anelli, L. (2024). Case report of possible abscopal effect in a patient with metastatic bladder cancer treated with radiotherapy and Artemisia compounds. International Journal of Integrative Oncology.

Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

Published on by Book of Award

Mrs. Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

University of Fribourg | Switzerland

Mrs. Sophie Grigolo is an emerging researcher specializing in cellular and molecular biology, with a strong focus on cancer research, particularly clear-cell renal-cell carcinoma (ccRCC). Her work encompasses extensive laboratory expertise in cell culture using human kidney cancer cell lines (A-498, ACHN, Caki-1, and Caki-2) and a range of analytical assays including BrdU Cell Proliferation, MTT, LDH, and Live-or-Dye™ Fixable Viability Staining. She is proficient in advanced molecular biology techniques such as polymerase chain reaction (PCR), agarose gel electrophoresis, western blotting, genotyping, flow cytometry, and immunohistochemistry (IHC), which she applies to elucidate cancer cell behavior and therapeutic responses. Her publications, including studies on immunotherapy in ccRCC and the role of IL-2 receptor expression in renal carcinoma cells, contribute to advancing understanding of tumor immunology and targeted therapies. Sophie has also shared her findings at prestigious scientific forums, including the International Student Congress of (bio)Medical Sciences and the Annual European Student Symposium on Anatomical Research, where her work has earned recognition for excellence. Through her research and technical acumen, she continues to contribute to the evolving field of cancer biology and the development of innovative therapeutic approaches.

Profile : Orcid

Featured Publications

Grigolo, S., Fellay, I., & Filgueira, L. (2025). IL-2 receptor expression in renal cell carcinoma cells: IL-2 influences cell survival and induces cell death. Current Issues in Molecular Biology, 47(10), 830.

Grigolo, S., & Filgueira, L. (2024). Immunotherapy of clear-cell renal-cell carcinoma. Cancers, 16, 2092.

Akanksha Sanghvi | Health Professions | Best Review Article Award

Published on by Book of Award

Dr. Akanksha Sanghvi | Health Professions | Best Review Article Award

Oprava Aesthetics | India

Dr. Akanksha Sanghvi is a globally trained dermatologist, aesthetic physician, researcher, author, and medical innovator, renowned for her expertise in clinical dermatology, trichology, regenerative medicine, and anti-aging science. As the Founder and Medical Director of Oprava Aesthetics, Mumbai, she has established one of India’s most advanced centers integrating evidence-based dermatology with aesthetic and regenerative therapies. Her research contributions include publications in leading journals such as the Journal of the European Academy of Dermatology and Venereology and the International Journal of Dermatology, along with authorship in Springer’s Handbook of Cancer and Immunology. A certified peer reviewer for Elsevier and Wiley, she holds two patents for dermatological instruments, with two more pending. Dr. Sanghvi’s pioneering work in stem cell and exosome therapy bridges science and clinical innovation, focusing on hair regeneration, skin rejuvenation, and autism care. Through her NGO, ODE INDIA, she leads an AI-powered tele-dermatology initiative to extend specialized care to rural communities. Recognized as the “Best Young Cosmetic Dermatologist of India,” she continues to advance global standards in aesthetic and regenerative dermatology, merging medical excellence with compassion and social responsibility.

Profile : Orcid

Featured Publications

Sanghvi, A. R. (2020). COVID-19: An overview for dermatologists. International Journal of Dermatology.

Shah, A., & Makhecha, M. (2016). Pustular psoriasis of pregnancy with acrodermatitis continua of Hallopeau. Indian Journal of Dermatology.

Shah, A., & Safaya, A. (2013). Spina bifida manifesta: Tethered cord syndrome with pilonidal sinus in a 4-month-old baby. Journal of Neuroradiology.

Shah, A., & Safaya, A. (2012). Granulomatous slack skin disease: A review, in comparison with mycosis fungoides. Journal of the European Academy of Dermatology and Venereology.

Bingbing Wu | Health Professions | Best Researcher Award

Published on by Book of Award

Dr. Bingbing Wu | Health Professions | Best Researcher Award

Zhejiang University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits

Dr. Bingbing Wu began his academic journey with a strong foundation in biological sciences and technology, later advancing to doctoral studies in animal science at Zhejiang University. His early academic training provided him with a deep understanding of cellular biology, developmental processes, and molecular mechanisms, which later became central to his research in regenerative medicine and women’s health. These formative years not only shaped his scientific curiosity but also set the stage for his future contributions to stem cell biology and tissue regeneration.

Professional Endeavors

Following his doctoral studies, Dr. Wu pursued postdoctoral research at Zhejiang University School of Medicine and The First Affiliated Hospital of Zhejiang University, where he investigated the molecular underpinnings of tissue regeneration and gynecological diseases. His professional path led him to roles as a research assistant, full-time researcher, and later junior principal investigator at Zhejiang University’s International School of Medicine. Each role deepened his expertise in applying cutting-edge technologies to complex medical problems and allowed him to cultivate leadership in research.

Contributions and Research Focus

Dr. Wu’s research is centered on stem cell biology, regenerative medicine, and women’s reproductive health. His work investigates key stem cells involved in endometrial development and regeneration, along with the regulatory mechanisms driving their differentiation. He applies single-cell and spatial multi-omics technologies to unravel the pathological basis of diseases such as intrauterine adhesions and preeclampsia. By integrating organoid models, he has advanced understanding of maternal-fetal interface formation and disease mechanisms, providing novel insights into therapeutic approaches for obstetric and gynecological conditions.

Accolades and Recognition

Throughout his career, Dr. Wu has earned prestigious recognition through numerous competitive research grants. He has been a principal investigator on projects funded by the National Natural Science Foundation of China and the Zhejiang Province Key Projects, reflecting the national and regional confidence in his scientific leadership. His publications in respected international journals such as ACS Applied Materials & Interfaces, Stem Cell Reports, Cell Discovery, and NPJ Regenerative Medicine highlight his contributions to the advancement of regenerative medicine and biomedical science.

Impact and Influence

Dr. Wu’s work has had a significant impact on the field of regenerative medicine, particularly in women’s reproductive health. His studies have not only elucidated molecular pathways of tissue development but also provided translational potential for developing bioactive materials and therapeutic interventions. By combining experimental and computational approaches, he has expanded the scope of regenerative research, inspiring peers and contributing to the global understanding of complex gynecological disorders.

Legacy and Future Contributions

As a scientist committed to innovation, Dr. Wu continues to push the boundaries of regenerative biology. His current projects focus on human adult uterine cell atlases, endometrial tissue engineering, and the role of specific stromal and immune cell populations in tissue regeneration. With ongoing leadership in funded projects and collaborations, he is shaping a scientific legacy that bridges fundamental biology with clinical application. His future contributions are expected to bring new hope for women suffering from reproductive health disorders.

Publications

Article: Autologous platelet-rich plasma dual-network hydrogel promotes human endometrial regeneration
Authors: Xiao Chen, Chengcheng Zhu, Lu Wang, Jialing Deng, Zhuomin Wang, Xiaolin Wu, Haimin Tan, Yiyuan Qu, Bingbing Wu, Yu Li, Keren Cheng, Jian Xu
Journal: Acta Biomaterialia
Year: 2025

Article: Natural regeneration-inspired sequential delivery of synergistic growth factors for structural and functional endometrial regeneration
Authors: Cheng Zhang, Chengcheng Zhu, Xiao Chen, Xuzhi Chen, Di Zhang, Huafei Zhao, Junwen Zhang, Yu Zhang, Wanwan Xu, Xiaofeng Zhao, Yingying Hu, Wei Wei, Jian Xu, Yu Li, Bingbing Wu
Journal: Acta Biomaterialia
Year: 2025

Article: Reshaping the chromatin landscape in HUVECs from small-for-gestational-age newborns
Authors: Lingling Yan, Zhimin Zhou, Shengcai Chen, Xin Feng, Junwen Mao, Fang Luo, Jianfang Zhu, Xiuying Chen, Yingying Hu, Yuan Wang, Bingbing Wu, Lizhong Du, Chunlin Wang, Liang Gong, Yanfen Zhu
Journal: JCI Insight
Year: 2025

Article: Size- and Dose-Dependent Body-Wide Organ Transcriptomic Responses to Calcium Phosphate Nanomaterials
Authors: Yu Li, Wei Jiang, Nanfang Nie, Jiaqi Xu, Xiaozhao Wang, Junwen Zhang, Jiahuan Guan, Chengcheng Zhu, Cheng Zhang, Ying Gu, Xiaoyi Chen, Shasha Yao, Zi Yin, Bingbing Wu*, Hongwei Ouyang*, Xiaohui Zou*
Journal: ACS Applied Materials & Interfaces
Year: 2023

Article: A Dual-Crosslinked Hydrogel Based on Gelatin Methacryloyl and Sulfhydrylated Chitosan for Promoting Wound Healing
Authors: Shunxian Ji, Yushuang Zhao, Xinrang Zhai, Lu Wang, Huali Luo, Zhiyong Xu, Wei Dong, Bingbing Wu*, Wei Wei*
Journal: International Journal of Molecular Sciences
Year: 2023

Conclusion

Dr. Bingbing Wu stands as a distinguished researcher whose academic dedication, professional achievements, and scientific contributions have left a lasting mark on regenerative medicine. His focus on stem cells, multi-omics, and endometrial regeneration has advanced both theoretical knowledge and applied therapeutic strategies. With continued research, mentorship, and innovation, he is poised to expand his influence further, leaving a legacy of discovery and practical impact in the field of health professions.

Armin Arshi | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Armin Arshi | Medicine and Dentistry | Best Researcher Award

NYU Langone Health | United States

Author Profile

Scopus

Google Scholar

🌱 Early Academic Pursuits

Dr. Armin Arshi began his academic journey with distinction, graduating Summa Cum Laude with a Bachelor of Science in Bioengineering from UCLA in 2012. He complemented his technical depth with a specialization in Materials Science and Engineering. Driven by a passion for medicine and innovation, he pursued his Doctor of Medicine at the David Geffen School of Medicine at UCLA, earning membership in the prestigious Alpha Omega Alpha (AΩA) Honor Medical Society and receiving multiple academic awards for excellence in research and leadership.

🏥 Professional Endeavors

Following medical school, Dr. Arshi underwent rigorous Orthopaedic Surgery residency training at UCLA, where he served as Administrative Chief Resident. He then pursued a Fellowship in Adult Reconstruction at the Rothman Orthopaedic Institute, a globally respected hub for joint replacement. His clinical career has included prominent roles as Attending Orthopaedic Surgeon at NYU Langone Health and currently at Beach Orthopaedic Specialty Institute and UCI Health in California. As an Assistant Professor at NYU Grossman School of Medicine, he has shaped orthopedic education and research.

🔬 Contributions and Research Focus

Dr. Arshi’s research spans joint arthroplasty, surgical outcomes, infection control, and implant biomechanics. He has authored numerous peer-reviewed publications in elite journals like The Journal of Arthroplasty and Arthroplasty Today, addressing topics from patient follow-up to periprosthetic joint infection and predictive modeling. His innovative studies have earned recognition at prestigious meetings including AAOS, NASS, and Western Orthopaedic Association. He has also contributed to surgical literature through influential book chapters and national guidelines.

🏅 Accolades and Recognition

Dr. Arshi’s excellence has been honored with the Stafford L. Warren Medal (UCLA’s highest medical school award), numerous resident research awards, and national research prizes, including the NIH DEBUT Competition and Howard Hughes Fellowships. His leadership in orthopedics is further affirmed through roles on editorial boards of major journals and review panels, demonstrating both scientific rigor and peer respect.

🌍 Impact and Influence

With a keen focus on evidence-based medicine, Dr. Arshi’s work has impacted clinical decision-making in joint replacement, particularly in VTE prophylaxis, return-to-sport protocols, and implant longevity. His efforts to understand disparities in patient outcomes and enhance surgical education have made significant strides in advancing personalized orthopedic care. He is a thought leader committed to improving both technical standards and patient experiences.

🔮 Legacy and Future Contributions

Poised at the intersection of clinical mastery and academic excellence, Dr. Arshi is a rising force in orthopaedics. His commitment to innovation, mentorship, and multidisciplinary collaboration positions him to be a lasting influence in orthopedic surgery and medical education. As he continues to lead in surgery, research, and institutional quality initiatives, his legacy will shape the next generation of joint reconstruction techniques and orthopedic leaders.

Publications

📄 Patient characteristics associated with loss to follow-up after total joint arthroplasty
• Authors: Ruff G, Sarfraz A, Lawrence KW, Arshi A, Rozell JC, Schwarzkopf R
• Journal: Journal of Arthroplasty
• Year: 2025

📄 Risk of early manipulation in cemented versus cementless total knee arthroplasty: analysis of the American Joint Replacement Registry
• Authors: Schaffler B, Zaniletti I, Arshi A, De M, Schwarzkopf R, Rozell JC
• Journal: Journal of Arthroplasty
• Year: 2025

📄 Why do total joint arthroplasties get canceled on the day of surgery?
• Authors: Sandoval CG, Katzman JL, Connolly P, Grossman EL, Arshi A, Schwarzkopf R
• Journal: Journal of Arthroplasty
• Year: 2025

📄 Total joint arthroplasty patients from distressed communities return to sports and physical activities at lower rates
• Authors: Cozzarelli NF, Khan IA, Arshi A, Sherman MB, Fillingham YA
• Journal: Journal of Arthroplasty
• Year: 2025

📄 Aseptic tibial loosening is associated with thickness of the cement: a radiographic case-control study
• Authors: Schaffler B, Robin JX, Katzman J, Arshi A, Rozell JC, Schwarzkopf R
• Journal: Journal of Arthroplasty
• Year: 2024